These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37845092)

  • 1. Determining the factors affecting chemotherapy-induced nausea and vomiting in children with cancer.
    Ay A; Boztepe H; Özbay SÇ; Yılmaz P; Karadavut B; Burhanoğulları D; Akyüz C
    J Pediatr Nurs; 2023; 73():e426-e434. PubMed ID: 37845092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
    Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
    Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of using an interactive mobile application for the management of chemotherapy-induced nausea and vomiting in children: Randomized controlled study.
    Semerci R; Akgün Kostak M; Taşkın C
    Eur J Oncol Nurs; 2022 Jun; 58():102121. PubMed ID: 35306247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study.
    Matsui R; Suzuki K; Takiguchi T; Nishio M; Koike T; Hayashi T; Seto T; Kogure Y; Nogami N; Fujiwara K; Kaneda H; Harada T; Shimizu S; Kimura M; Kenmotsu H; Shimokawa M; Goto K
    BMC Pharmacol Toxicol; 2020 Oct; 21(1):72. PubMed ID: 33023657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.
    Vanbockstael J; Coquan E; Gouerant S; Allouache D; Faveyrial A; Noal S; Delcambre C; Galais MP; Héron JF; Lefebvre AC; Sevin E; Hrab I; Polycarpe F; André M; Kaluzinski L; Gervais R; Gunzer K; Vié B; Saucier G; Lemenand N; Grellard JM; Clarisse B; Dugué AE; Joly F
    Support Care Cancer; 2016 Mar; 24(3):1131-8. PubMed ID: 26268784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of antiemetic in reducing chemotherapy-induced nausea and vomiting in adult patients; An oncology center experience.
    Al-Salloum HF; Al-Harbi HE; Abdelazeem A
    J Oncol Pharm Pract; 2023 Sep; 29(6):1317-1325. PubMed ID: 36518002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nausea and vomiting perspectives among children receiving moderate to highly emetogenic chemotherapy treatment.
    Rodgers C; Kollar D; Taylor O; Bryant R; Crockett K; Gregurich MA; Hockenberry M
    Cancer Nurs; 2012; 35(3):203-10. PubMed ID: 21915041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update.
    Patel P; Robinson PD; Phillips R; Baggott C; Devine K; Gibson P; Guilcher GMT; Holdsworth MT; Neumann E; Orsey AD; Spinelli D; Thackray J; van de Wetering M; Cabral S; Sung L; Dupuis LL
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30395. PubMed ID: 37178438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.
    Willier S; Cabanillas Stanchi KM; von Have M; Binder V; Blaeschke F; Feucht J; Feuchtinger T; Döring M
    BMC Cancer; 2019 Nov; 19(1):1118. PubMed ID: 31730451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children.
    Dupuis LL; Nathan PC
    Paediatr Drugs; 2003; 5(9):597-613. PubMed ID: 12956617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.
    Liau CT; Chu NM; Liu HE; Deuson R; Lien J; Chen JS
    Support Care Cancer; 2005 May; 13(5):277-86. PubMed ID: 15770489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children's coping strategies for chemotherapy-induced nausea and vomiting.
    Rodgers C; Norville R; Taylor O; Poon C; Hesselgrave J; Gregurich MA; Hockenberry M
    Oncol Nurs Forum; 2012 Mar; 39(2):202-9. PubMed ID: 22374494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high dose methotrexate.
    Vol H; Flank J; Lavoratore SR; Nathan PC; Taylor T; Zelunka E; Maloney AM; Lee Dupuis L
    Support Care Cancer; 2016 Mar; 24(3):1365-71. PubMed ID: 26335406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chemotherapy-induced nausea and vomiting.
    Dewan P; Singhal S; Harit D
    Indian Pediatr; 2010 Feb; 47(2):149-55. PubMed ID: 20228428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline.
    Patel P; Robinson PD; Cohen M; Devine K; Gibson P; Holdsworth MT; Neumann E; Orsey A; Phillips R; Spinelli D; Thackray J; van de Wetering M; Woods D; Cabral S; Sung L; Dupuis LL
    Pediatr Blood Cancer; 2022 Dec; 69(12):e30001. PubMed ID: 36221901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the relationship between adherence with antiemetic drug therapy and control of nausea and vomiting in breast cancer patients receiving anthracycline-based chemotherapy.
    Chan A; Low XH; Yap KY
    J Manag Care Pharm; 2012 Jun; 18(5):385-94. PubMed ID: 22663171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.
    Ihbe-Heffinger A; Ehlken B; Bernard R; Berger K; Peschel C; Eichler HG; Deuson R; Thödtmann J; Lordick F
    Ann Oncol; 2004 Mar; 15(3):526-36. PubMed ID: 14998860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting.
    Molassiotis A; Stamataki Z; Kontopantelis E
    Support Care Cancer; 2013 Oct; 21(10):2759-67. PubMed ID: 23715816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.